no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Antithrombotic Agents in Coronary Artery Disease
|
Cairns, John A. |
|
1992 |
102 |
4S |
p. 456S-481S nvt p. |
article |
2 |
Antithrombotic Therapy for Cerebrovascular Disorders
|
Sherman, David G. |
|
1992 |
102 |
4S |
p. 529S-537S nvt p. |
article |
3 |
Antithrombotic Therapy for Venous Thromboembolic Disease
|
Hyers, Thomas M. |
|
1992 |
102 |
4S |
p. 408S-425S nvt p. |
article |
4 |
Antithrombotic Therapy in Atrial Fibrillation
|
Laupacis, Andreas |
|
1992 |
102 |
4S |
p. 426S-433S nvt p. |
article |
5 |
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
|
Stein, Paul D. |
|
1992 |
102 |
4S |
p. 445S-455S nvt p. |
article |
6 |
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts Following Percutaneous Transluminal Coronary Angioplasty
|
Stein, Paul D. |
|
1992 |
102 |
4S |
p. 508S-515S nvt p. |
article |
7 |
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
|
Clagett, G. Patrick |
|
1992 |
102 |
4S |
p. 516S-528S nvt p. |
article |
8 |
Antithrombotic Therapy in Valvular Heart Disease
|
Levine, Herbert J. |
|
1992 |
102 |
4S |
p. 434S-444S nvt p. |
article |
9 |
Aspirin and Other Platelet-Active Drugs
|
Hirsh, Jack |
|
1992 |
102 |
4S |
p. 327S-336S nvt p. |
article |
10 |
Assessment of the Therapeutic Use of n-3 Fatty Acids in Vascular Disease and Thrombosis
|
Goodnight, Scott H. |
|
1992 |
102 |
4S |
p. 374S-384S nvt p. |
article |
11 |
Coronary Thrombolysis
|
Cairns, John A. |
|
1992 |
102 |
4S |
p. 482S-507S nvt p. |
article |
12 |
Decision Analytic and Cost-Effectiveness Issues Concerning Anticoagulant Prophylaxis in Heart Disease
|
Eckman, Mark H. |
|
1992 |
102 |
4S |
p. 538S-549S nvt p. |
article |
13 |
Hemorrhagic Complications of Anticoagulant Treatment
|
Levine, Mark N. |
|
1992 |
102 |
4S |
p. 352S-363S nvt p. |
article |
14 |
Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism
|
Levine, Mark N. |
|
1992 |
102 |
4S |
p. 364S-373S nvt p. |
article |
15 |
Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety
|
Hirsh, Jack |
|
1992 |
102 |
4S |
p. 337S-351S nvt p. |
article |
16 |
Oral Anticoagulants
|
Hirsh, Jack |
|
1992 |
102 |
4S |
p. 312S-326S nvt p. |
article |
17 |
Prevention of Venous Thromboembolism
|
Clagett, G. Patrick |
|
1992 |
102 |
4S |
p. 391S-407S nvt p. |
article |
18 |
Rules of Evidence and Clinical Recommendations on the Use of Antithrombotic Agents
|
Cook, Deborah J. |
|
1992 |
102 |
4S |
p. 305S-311S nvt p. |
article |
19 |
Use of Antithrombotic Agents During Pregnancy
|
Ginsberg, Jeffrey S. |
|
1992 |
102 |
4S |
p. 385S-390S nvt p. |
article |